USA: A large multicenter randomized clinical trial has found that administering budesonide mixed with surfactant did not ...

Sanofi is conducting a Phase 3 clinical trial titled A Randomized, Phase 3, Double-blind, 52-week Study to Evaluate the Efficacy and Safety of Rilzabrutinib (SAR444671) Compared to Placebo in Adult ...

A randomized phase 2 peri-operative (neoadjuvant plus adjuvant) study of fianlimab (anti–LAG-3) plus cemiplimab (anti–PD-1) versus anti–PD-1 alone in patients with resectable stage III and IV melanoma ...

A phase 2 study of response-guided neoadjuvant sacituzumab govitecan and pembrolizumab (SG/P) in patients with early-stage triple-negative breast cancer: Results from the NeoSTAR trial. This is an ...

Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...

The Phase 2b study demonstrated a statistically significant dose-response relationship at the primary endpoint following a single administration of MM120 across four dose levels, with improvements ...

Many trials that measure the efficacy and safety of antidepressants for MDD exclude one third of real-world patients with the ...

EXECUTIVE CHAIRMAN & CEO OF MEDICUS TO PARTICIPATE IN A FIRESIDE CHAT WITH EQUITY RESEARCH ANALYST PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / October 13, 2025 / Medicus Pharma Ltd. (NASDAQ:MDCX) ( ...

School is in session, and viral illness is on the rise. A new study suggests that lowering exposure to respiratory viruses in classrooms isn’t as simple as adding high-efficiency particulate air (HEPA ...

Calcium supplements do not appear to raise dementia risk. Long-term data support their safety for older women. New findings from (ECU), Curtin University, and the University of Western Australia show ...